Covid Report: Gilead Nears Coronavirus Data In 'Weeks'; J&J Bullish On Vaccine
A flurry of news about potential coronavirus treatments and vaccines helped shares of biopharmas Gilead Sciences, Regeneron Pharmaceuticals and Johnson & Johnson to pop Monday.